Composition containing camellia oil as well as preparation method and application thereof in cosmetics

By combining camellia oil, beef tendon vine extract and evening primrose extract, yeast fermentation improves the activity of beef tendon vine extract and forms an anti-inflammatory composition, solving the single ingredient and extraction process of existing anti-inflammatory skin care products. Simple questions achieve significant repair and anti-inflammatory effects, improving skin healing and barrier repair functions.

CN119055570AInactive Publication Date: 2024-12-03AMY NEW MATERIALS (NANTONG) CO LTD
View PDF 2 Cites 0 Cited by

Patent Information

Application Number
CN202411208217.1
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-08-30
Publication Date
2024-12-03
Estimated Expiration
Not applicable · inactive patent

AI Technical Summary

Technical Problem

Most of the existing anti-inflammatory skin care products only contain a single ingredient, which is difficult to cope with complex and changeable skin inflammation problems. The extraction process is simple and the active ingredients in the raw materials cannot be fully retained, resulting in limited product effects.

Method used

Using a composition of camellia oil, beef tendon vine extract and evening primrose extract, the residue is extracted by mixing fermenting yeast with Pichia yeast to improve its activity and richness, and with camellia oil and evening primrose Grass extract is combined to form an anti-inflammatory composition for the preparation of resident skin-like topical agents.

Benefits of technology

It significantly improves the repair and anti-inflammatory effects of the product, promotes wound healing, and improves the skin's own barrier repair function, and is more effective than using alone under the same amount of use, resulting in significant synergistic efficiency.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure SMS_1
    Figure SMS_1
  • Figure SMS_2
    Figure SMS_2
  • Figure SMS_3
    Figure SMS_3
Patent Text Reader

Abstract

The invention discloses a composition containing camellia oil as well as a preparation method and application thereof in cosmetics, and belongs to the field of dressing preparations. The composition is prepared from the following raw materials: camellia oil, eleusine indica extract and evening primrose extract. The composition has the effects of resisting inflammation, repairing and the like; and a human body patch test shows that the mask does not obviously become red, and is mild and non-irritant.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention belongs to the field of cosmetic preparations, and in particular relates to a composition containing camellia oil, a preparation method thereof and application of the composition in cosmetics. Background Art

[0002] Skin inflammation not only causes discomfort symptoms such as redness, swelling, itching, and pain, but may also further cause long-term problems such as skin aging and pigmentation. Therefore, it is particularly important to develop a skin care product that can effectively relieve skin inflammation and protect skin health.

[0003] There are many kinds of anti-inflammatory skin care products on the market, but most of them only contain a single anti-inflammatory ingredient, which is difficult to deal with the complex and changeable skin inflammation problems. In addition, the extraction process of some products is simple and cannot fully retain the active ingredients in the raw materials, resulting in limited product effects. Therefore, the development of an anti-inflammatory skin care product with multi-ingredient synergy, optimized extraction process and significant effect has become an urgent need in the current skin care field. Summary of the invention

[0004] The invention provides a composition containing camellia oil, a preparation method thereof and application of the composition in cosmetics, and the composition has anti-inflammatory, repairing and other effects through natural ingredients extracted from plants.

[0005] In order to achieve the above object, the present invention adopts the following technical solutions:

[0006] Camellia oil: extracted from the seeds of the camellia tree, Theaceae family.

[0007] Malaisia ​​scandens (Lour.) Planch.: A thornless climbing shrub of the genus Malaisia ​​in the Moraceae family, widely distributed in Asia, Oceania and other regions.

[0008] Beautiful Evening Primrose (Oenothera speciosaNutt.): a plant of the genus Oenothera in the Onagraceae family.

[0009] In a first aspect, the present invention provides a method for preparing an extract of Achyranthes bidentata var.

[0010] T1: Wash, remove impurities, slice, dry and crush the roots of Rhizoma Cynanchum to obtain A1;

[0011] T2: Add twice the mass of water to A1 and homogenize to obtain A2;

[0012] T3: After A2 is soaked at room temperature for 12 hours, Rhizopus arrhizus is added, and the mixture is fermented at room temperature for ≥15 days, and filtered to obtain the residue A4. The filtrate is dried to obtain A3;

[0013] T4: Add twice the mass of A1 into water-saturated ethyl acetate, homogenize to obtain B2;

[0014] T5: heat B2 to 45-55°C, reflux extract, filter, filter residue B4, and dry the filtrate to obtain B3;

[0015] T6: A4 and B4 are washed, dried, sterilized, mixed, and hydrolyzed with cellulase to obtain filtrate S1;

[0016] T7: S1 is mixed and fermented with Saccharomyces cerevisiae and Pichia pastoris. After fermentation for 7-14 days, the fermentation filtrate is obtained by oscillation filtration, and the filtrate is dried to obtain S2.

[0017] Furthermore, the pulverization in T1 is performed by using an air flow superfine pulverizer, and the pulverized particle size is 7000±500 mesh;

[0018] Furthermore, the amount of Rhizopus arrhizus added in T3 is 12wt%±2wt% of the fermented raw material;

[0019] Furthermore, the amount of cellulase added in T6 is 11wt%±1wt% of the raw material to be hydrolyzed;

[0020] Furthermore, the amount of the fermentation bacteria in T7 is 9wt%±1wt% of the fermented raw material;

[0021] Furthermore, the mass ratio of the Saccharomyces cerevisiae and Pichia pastoris described in T7 is 1:3;

[0022] Furthermore, the oscillation filtration in T7 means that after the fermentation is completed, ultrasonic oscillation is used to lyse the bacterial cells to make their contents flow out, and then the cells are filtered to remove impurities, wherein the filter pore size is 100 μm.

[0023] In a second aspect, the present invention provides an anti-inflammatory composition, the specific formulation of which is as follows:

[0024] Camellia oil: 6-8 parts;

[0025] Rhizoma Cynanchum extract: 8-12 parts;

[0026] Evening primrose extract: 4-6 parts.

[0027] Furthermore, the antioxidant composition has the following raw material mass proportions:

[0028] Camellia oil: 7-8 parts;

[0029] Rhizoma Cynanchum extract: 9-12 parts;

[0030] Evening primrose extract: 5-6 parts.

[0031] Furthermore, the anti-inflammatory composition has the following raw material mass proportions:

[0032] Camellia oil: 8 parts;

[0033] Rhizoma Cynanchum extract: 10-12 parts;

[0034] Evening primrose extract: 5 parts.

[0035] In a third aspect, the present invention provides a formulation ratio of a leave-on skin topical preparation, the specific formulation ratio of which is as follows:

[0036] The external preparation comprises 8-12 wt % of the composition, 6 wt % of betaine, 1 wt % of sodium hyaluronate and 4 wt % of honey.

[0037] Furthermore, the external preparation comprises 8wt% of the composition, 6wt% of betaine, 1wt% of sodium hyaluronate, and 4wt% of honey.

[0038] Compared with the prior art, the beneficial effects of the present invention are as follows: the present invention innovatively uses a mixture of Saccharomyces paradoxus and Pichia pastoris to ferment the raw material of the Angustifolia extract residue after cellulase hydrolysis, and the activity and richness of ketones and alkaloids in the raw material of the Angustifolia extract residue after double mixed fermentation are significantly improved, and the functionality and application pathways of natural products such as glycosides, terpenes and plant polysaccharides are significantly improved. And as the enzymatic hydrolysis product is mixed with the ester extraction product and the water extraction product, and then matched with camellia oil and evening primrose extract, the prepared resident skin topical agent has significant repair, anti-inflammatory and other effects. And it can also significantly help wound healing, promote cell migration rate, and improve the skin's own barrier repair function.

[0039] It has been found through experiments that the composition can repair skin damage caused by various reasons, has repairing and anti-inflammatory effects, and is suitable for various skin types. The present invention has found that under the premise of the same usage amount, the composition of the proportion defined in the present invention has better effects than using it alone, produces a significant synergistic effect, and has better repairing and anti-inflammatory effects. The present invention also provides the preferred formula and preparation method of the repairing and anti-inflammatory skin care product. DETAILED DESCRIPTION

[0040] In order to better understand the present invention, the present invention is further described below in conjunction with specific examples, wherein the terms used in the examples are for describing specific embodiments and do not constitute limitations on the scope of protection of the present invention.

[0041] The experimental methods in the following examples without specifying specific conditions are usually carried out under conventional conditions or under conditions recommended by the manufacturer. Unless otherwise specified, percentages and parts are calculated by weight.

[0042] Some raw materials and their sources are as follows:

[0043] Camellia oil: purchased from Jiangxi Chunyuan Green Food Co., Ltd.

[0044] Roots and leaves of Malaisia ​​scandens (Lour.) Planch.: collected from South China Botanical Garden.

[0045] Broussonetiakaempferi var.australis T.Suzuki: collected from South China Botanical Garden.

[0046] Evening primrose (Oenothera speciosaNutt.) extract: purchased from Xi'an Xuhuang Biotechnology Co., Ltd.

[0047] Rhizopus arrhizus: Ningbo Mingzhou Biotechnology Co., Ltd.

[0048] Rhizopus niger: Ningbo Mingzhou Biotechnology Co., Ltd.

[0049] Pichia pastoris: Ningbo Mingzhou Biotechnology Co., Ltd.

[0050] Saccharomyces paradoxus: Ningbo Mingzhou Biotechnology Co., Ltd.

[0051] Saccharomyces cerevisiae: Ningbo Mingzhou Biotechnology Co., Ltd.

[0052] Preparation, comprising the following steps:

[0053] The specific steps of extracting the Angustifolia vine extract are as follows:

[0054] T1: Wash, remove impurities, slice, dry and crush the roots of Rhizoma Cynanchum to obtain A1;

[0055] T2: Add twice the mass of water to A1 and homogenize to obtain A2;

[0056] T3: After A2 is soaked at room temperature for 12 hours, Rhizopus arrhizus is added, and the mixture is fermented at room temperature for ≥15 days, filtered to obtain the filtrate, and freeze-dried to obtain A3 and the filter residue A4;

[0057] T4: Add twice the mass of A1 into water-saturated ethyl acetate, homogenize to obtain B2;

[0058] T5: heating B2 to 45-55°C, reflux extraction, filtering to obtain the filtrate, drying to obtain B3 and filter residue B4;

[0059] T6: A4 and B4 are washed, dried and mixed, and then enzymatically hydrolyzed with cellulase to obtain filtrate S1;

[0060] T7: S1 was mixed and fermented with Saccharomyces cerevisiae and Pichia pastoris. After fermentation for 7-14 days, the fermentation filtrate was obtained by oscillation filtration, and then freeze-dried to obtain S2.

[0061] In Example 1, following steps T1-T7, A3, B3, and S2 are mixed to obtain X1; X1 is the final product.

[0062] Comparative Example 1, following steps T1-T3, with A3 as the final product.

[0063] Comparative Example 2, following steps T1, T4, and T5, with B3 as the final product.

[0064] Comparative Example 3, following steps T1-T5, the final product is a mixture of A3 and B3, X2.

[0065] Comparative Example 4, following steps T1-T7, with S2 as the final product.

[0066] In comparative example 5, the Rhizopus arrhizus in T3 was changed to Rhizopus nigrosus, and the remaining steps were the same as those in example 1.

[0067] In Comparative Example 6, T7 paradoxomyces and Pichia pastoris were replaced with paradoxomyces pastoris, and the remaining steps were the same as those in Example 1.

[0068] In comparative example 7, T7 paradoxomyces and Pichia pastoris were replaced with Pichia pastoris, and the remaining steps were the same as those in example 1.

[0069] In comparative example 8, the T7 paradox yeast was replaced with cerevisiae yeast, and the remaining steps were the same as those in example 1.

[0070] In Comparative Example 9, Pichia pastoris T7 was replaced with Saccharomyces cerevisiae, and the remaining steps were the same as those in Example 1.

[0071] In comparative example 10, the roots of Rhizoma Cynanchum are replaced with Rhizoma Cynanchum leaves, and the remaining steps are the same as those in example 1.

[0072] In comparative example 11, the roots of Rhizoma Cynanchum are replaced with those of Rhizoma Cynanchum, and the remaining steps are the same as those of example 1.

[0073] The mass ratio of the anti-inflammatory composition is shown in Table 1;

[0074] Table 1

[0075]

[0076] The specific mass percentage ratios of the leave-on skin topical preparations are shown in Table 2;

[0077] Table 2

[0078]

[0079]

[0080] Note: Make up the balance with deionized water.

[0081] The specific mass proportions of the preparation of the leave-on skin topical preparation are as follows:

[0082] The external preparation comprises 8-12 wt % of the composition, 6 wt % of betaine, 1 wt % of sodium hyaluronate and 4 wt % of honey.

[0083] Furthermore, the external preparation comprises 8wt% of the composition, 6wt% of betaine, 1wt% of sodium hyaluronate, and 4wt% of honey.

[0084] The specific preparation steps for the preparation of the leave-on skin topical preparation are as follows:

[0085] T1: Add betaine and honey into water, heat to 60-70℃, stir and homogenize;

[0086] T2: After T1 is homogenized, cool to ≤45°C, add the composition and sodium hyaluronate, homogenize, sterilize, and seal.

[0087] Safety testing.

[0088] With reference to the 2015 Technical Specifications for Safety of Cosmetics, the skin care gels of Examples 5-9 were evaluated for cosmetic irritation. The test method was a skin patch test, and 50 randomly distributed people aged 16-65 were tested.

[0089] Test method: Put the test substance into the patch tester, the dosage is 0.020-0.025g, cover the patch tester with the test substance on the back or forearm of the subject with non-irritating cloth-based tape, and gently press it with the palm to make it evenly adhere to the skin surface for 24 hours. After removing the test patch tester, observe the skin reaction after the indentation disappears 30 minutes later. If the result is negative, observe again 24 hours and 48 hours after the patch test.

[0090] Evaluation criteria:

[0091] Grade 0: negative reaction;

[0092] Grade 1: Suspicious reaction, only slight erythema;

[0093] Grade 2: weak positive reaction, erythema, infiltration, edema, and papules may be present;

[0094] Grade 3: Strong positive reaction, erythema, infiltration, edema, papules, and the reaction may extend beyond the test area;

[0095] Grade 4: Very strong positive reaction, obvious erythema, severe infiltration, edema, confluent herpes, and the reaction exceeds the test area.

[0096] Test results: Skin reactions were negative in all subjects.

[0097] The above test results show that the leave-on skin topical preparation provided by the present invention is mild and non-irritating to the skin and is safe to use.

[0098] ABTS + Free radical inhibition experiment

[0099] Take 7mmol / LABTS + 5mL and 88μL of 140mmo l / L potassium persulfate were mixed evenly to prepare ABTS + Free radical stock solution, keep away from light for future use. Take 0.1mL, 10mg / L test solution of Examples 5-9 and Comparative Examples 26-40, add 3.9mL ABTS + The working solution was shaken for 30 seconds and allowed to stand at room temperature for 6 minutes. The absorbance was measured at 734 nm with anhydrous ethanol as the control and Vc as the positive control. Each sample was measured 3 times and the scavenging rate of ABTS+ free radicals was calculated according to the following formula:

[0100]

[0101] Where Ai is the absorbance value of the test solution; Aj is the background value of the test solution; A0 is the control value without adding the test solution.

[0102] Table 3 ABTS + Free radical scavenging rate

[0103]

[0104]

[0105] Comparing the results of Examples 5-9 with Comparative Examples 26-40, it can be seen that the specific combination and specific ratio of the present invention can significantly improve the ABTS + Free radical scavenging rate.

[0106] Comparing the results of Examples 5-9, it can be seen that the use of the specific combination and specific ratio of the present invention can significantly improve the ABTS +As for the free radical scavenging rate, Example 7 has the best effect. By comparing the results of Examples 5-7, it can be seen that with the increase of the added amount, the scavenging rate also increases steadily, but the increase rate and the added amount do not show a linear relationship. Therefore, for cost-effectiveness considerations, Example 5 is selected as the optimal example.

[0107] Comparing the results of Example 5 with Comparative Examples 26-36, it can be seen that the composition composed of the extracts extracted by the specific extraction method of the present invention has an effect on ABTS + The free radical scavenging rate has a significant scavenging effect. Extracts extracted by steps, extraction sites or extraction methods not specified by the present invention cannot achieve the scavenging effect specified by the present invention.

[0108] Comparing the results of Example 5 with Comparative Examples 37-39, it can be seen that the specific combination and specific ratio of the present invention can significantly improve the ABTS + Free radical scavenging rate, there is a synergistic effect among the components of the present invention.

[0109] Comparison of the results of Example 5 and Comparative Example 40 shows that the composition provided by the present invention has a significant effect in removing ABTS. + Free radical action.

[0110] Inflammatory factor inhibition test

[0111] TNF-α is the most common inflammatory factor in inflammatory reactions. It can induce the phenotype of vascular endothelial cells to change to an inflammatory type, leading to changes in the body's metabolism and hemodynamics, and promoting the production of inflammatory mediators. Inflammatory mediators can increase vascular permeability, causing local congestion and edema, and may stimulate nerve endings to cause itching and pain. Therefore, the inhibition of TNF-α helps soothe and repair the skin.

[0112] RAW264.7 cells grown to the logarithmic phase were cultured at 1.5×10 5 Cells were inoculated at a density of 100 μg / mL in a 24-well plate, with 800 μL of cell suspension per well, and cultured in a 37°C, 5% CO2 incubator for 24 hours. When the cells grew to near fusion, 50 μL of the sample concentration of 10 mg / L was administered, with 3 replicates per group. The positive control was 50 μL of 10 μg / mL dexamethasone, and 1 μg / mL lipopolysaccharide (LPS) was used for stimulation 1 hour later. After incubation in a cell culture incubator for 24 hours, the cell culture fluid was transferred to a centrifuge tube, centrifuged at 5000 r / min for 10 minutes, and the cell supernatant was collected and tested according to the instructions of the TNF-α enzyme-linked immunosorbent assay kit.

[0113]

[0114] Table 4 Results of RAW secretion of TNF-α

[0115]

[0116]

[0117] By comparing the results of Examples 5-9 with Comparative Examples 26-40, it can be seen that the use of the specific combination and specific ratio of the present invention can significantly improve the inhibition rate of TNF-α secretion of the composition.

[0118] By comparing the results of Examples 5-9, it can be seen that the TNF-α secretion inhibition rate can be significantly improved when the specific combination and specific ratio of the present invention are used, among which Example 7 has the best effect. By comparing the results of Examples 5-7, it can be seen that with the increase of the added amount, the inhibition rate is also steadily increasing, but the increase rate and the added amount do not show a linear relationship. Therefore, for cost-effectiveness considerations, Example 5 is selected as the optimal example.

[0119] By comparing the results of Example 5 with Comparative Examples 26-36, it can be seen that the composition composed of the extracts extracted using the specific extraction method of the present invention has a significant inhibitory effect on the secretion of TNF-α, and the extracts extracted by steps, extraction sites or extraction methods not specified by the present invention cannot achieve the inhibitory effect specified by the present invention.

[0120] By comparing the results of Example 5 with Comparative Examples 37-39, it can be seen that the secretion inhibition rate of TNF-α can be significantly improved when the specific combination and specific ratio of the present invention are used, and there is a synergistic effect between the components of the present invention.

[0121] Comparison of the results of Example 5 and Comparative Example 40 shows that the composition provided by the present invention has a significant effect of inhibiting the secretion of TNF-α.

[0122] Effects of the composition on the migration of Hacat cells through scratch wound

[0123] The degree of cell migration has an important impact on wound healing and skin repair. In the process of wound healing, cell migration is an important step for epidermal cells to cover the wound, so the higher the cell migration rate, the faster the wound heals. At the same time, cell migration is also involved in the repair process after skin damage. If cell migration is impaired, it will lead to skin repair disorders, which in turn cause various skin diseases.

[0124] Cells were inoculated into 12-well plates at the corresponding inoculation density and incubated overnight at 37°C in a CO2 incubator. When the cell plating rate in the 12-well plate reached about 80%, the sample group and the solvent control group were scratched. After the scratching, the cells were washed with PBS to remove dead cells, and fresh EGF-free keratinocyte culture fluid was added. According to Example 5-9 and Comparative Example 26-40 10mg / L 50μL was added, and the culture was incubated in a 37°C, 5% CO2 incubator for 24h, and statistical analysis was performed using ImageJ software.

[0125] Table 5 Hacat cell migration rate

[0126] Experimental Group Hacat cell migration rate / % Example 5 90.66 Example 6 91.24 Example 7 90.17 Example 8 88.79 Example 9 86.73 Comparative Example 26 24.14 Comparative Example 27 21.43 Comparative Example 28 29.75 Comparative Example 29 28.41 Comparative Example 30 32.57 Comparative Example 31 29.24 Comparative Example 32 33.49 Comparative Example 33 30.17 Comparative Example 34 19.32 Comparative Example 35 48.41 Comparative Example 36 42.51 Comparative Example 37 35.24 Comparative Example 38 34.17 Comparative Example 39 15.22 Comparative Example 40 1.07 Positive Control 100

[0127] Comparing the results of Examples 5-9 with Comparative Examples 26-40, it can be seen that the cell migration rate can be significantly improved when the specific combination and specific ratio of the present invention are used.

[0128] By comparing the results of Examples 5-9, it can be seen that the cell migration rate can be significantly improved when the specific combination and specific ratio of the present invention are used, among which Example 7 has the best effect. By comparing the results of Examples 5-7, it can be seen that with the increase of the added amount, the inhibition rate is also steadily increasing, but the improvement rate and the added amount do not show a linear relationship. Therefore, for cost-effectiveness considerations, Example 5 is selected as the optimal example.

[0129] Comparing the results of Example 5 with Comparative Examples 26-36, it can be seen that the composition composed of the extracts extracted using the specific extraction method of the present invention has a significant effect on improving cell migration rate.

[0130] By comparing the results of Example 5 with Comparative Examples 37-39, it can be seen that the cell migration rate can be significantly improved when the specific combination and specific ratio of the present invention are used. There is a synergistic effect between the components of the present invention. The ratios and components not specified by the present invention cannot achieve the improvement in migration rate specified by the present invention.

[0131] By comparing the results of Example 5 with those of Comparative Example 40, it can be seen that the composition provided by the present invention has a significant effect of improving cell migration rate.

[0132] Test on the immediate repair effect of skin care gel on human body

[0133] Transepidermal water loss (TEWL) is an important parameter for evaluating skin barrier function. It indicates the loss of water from the deep dermis through evaporation of the epidermis. The higher the TEWL, the more water is lost through the skin and the weaker the skin's moisturizing ability.

[0134] The transepidermal water loss rate is closely related to the hydration of the stratum corneum and is a commonly used indicator reflecting the barrier function of the stratum corneum. In the development of cosmetics, the efficacy of moisturizing cosmetics can be evaluated by testing the TEWL value of skin water loss. In addition, the transepidermal water loss rate can also be used in allergic patch tests, contact dermatitis, physical therapy, burns and new tissue monitoring to promptly detect whether the protective function of the skin has been damaged.

[0135] Therefore, transepidermal water loss rate is an important parameter for assessing skin health and is of great significance to the research, development and evaluation of moisturizing products.

[0136] 60 healthy subjects aged 18-60 years old with no injuries on the inner arm were selected and divided into groups, with 10 people in each group, including 5 males and 5 females. A sample group and a blank group (i.e., negative control group: no test sample) were set up, and the test area was randomly distributed 1cm inside the volunteer's arm. 2 Area. The forearms (two areas) of the above-mentioned subjects were torn off with medical tape 20 times to induce damage to the skin barrier function, and then 5 mg / mL histamine was added to model for 10 minutes (obvious erythema appeared). One area was treated with 1g of the test product, and the other area was blank as a negative control area. The transepidermal water loss rate (TEWL) of the forearm skin was collected before tape tearing off (T0), before using the product (i.e., immediately after histamine) (T1), and 2 hours after using the product (T2). The difference in skin index changes between the product-treated area and the negative control area before and after using the product was used to evaluate the short-term repair effect of the product on skin barrier damage caused by tape tearing and histamine-induced skin irritation, and the average value was taken. The results are shown in Table 6 below.

[0137]

[0138] Table 6

[0139]

[0140]

[0141] According to the results in Table 6: From the results of Examples 5-9, the gel prepared by the composition has significant efficacy, and the composition of Example 5 has the best efficacy.

[0142] Example 5 and Comparative Example 40 show that the composition can effectively enhance the repairing effect.

[0143] The embodiments described above are part of the embodiments of the present application, rather than all of the embodiments. The detailed description of the embodiments of the present application is not intended to limit the scope of the present application for protection, but merely represents the selected embodiments of the present application. Based on the embodiments in the present application, all other embodiments obtained by those skilled in the art without making creative work are within the scope of protection of the present application.

Claims

1. An anti-inflammatory composition, characterized in that The composition comprises the following raw materials in parts by weight: Camellia oil: 6-8 parts; Rhizoma Cynanchum extract: 8-12 parts; Evening primrose extract: 4-6 parts.

2. The composition according to claim 1, characterized in that The composition comprises the following raw materials in parts by weight: Camellia oil: 7-8 parts; Rhizoma Cynanchum extract: 9-12 parts; Evening primrose extract: 5-6 parts.

3. The composition according to claim 2, characterized in that The composition comprises the following raw materials in parts by weight: Camellia oil: 8 parts; Rhizoma Cynanchum extract: 10-12 parts; Evening primrose extract: 5 parts.

4. A composition according to any one of claims 1 to 3, characterized in that The preparation process of the Cynanchum rotundum extract is as follows: T1: remove impurities from the roots of Rhizoma Cynanchum, slice them, dry them, and grind them to obtain A1; T2: Add twice the mass of water to A1 and homogenize to obtain A2; T3: After A2 is soaked at room temperature for 12 hours, Rhizopus arrhizus is added, and the mixture is fermented at room temperature for ≥15 days, filtered to obtain a filtrate, a filter residue A4, and the filtrate is dried to obtain A3; T4: Add twice the mass of A1 into water-saturated ethyl acetate, homogenize to obtain B2; T5: heating B2 to 45-55°C, reflux extraction, filtering to obtain a filtrate and a filter residue B4, and drying the filtrate to obtain B3; T6: A4 and B4 are washed, dried and sterilized, mixed, and hydrolyzed with cellulase to obtain filtrate S1; T7: S1 is mixed and fermented with Saccharomyces cerevisiae and Pichia pastoris for 7-14 days, and the fermentation filtrate is filtered to obtain the fermentation filtrate, and the filtrate is dried to obtain S2.

5. The composition according to claim 4, characterized in that The T3 fermentation environmental parameters are: temperature: normal temperature, pressure: normal pressure, oxygen content: 8-12%, humidity 70-80%, and initial pH: 5-6.

6. The composition according to claim 4, characterized in that The T7 fermentation environmental parameters are: temperature: normal temperature, pressure: normal pressure, oxygen content: 5-7%, humidity 80-85%, initial pH: 5.8-7.

2.

7. A leave-on skin external preparation, characterized in that: Comprising the composition according to any one of claims 1 to 6.

8. The external preparation according to claim 7, characterized in that: The external preparation contains 8-12 wt % of the composition.

9. The external preparation according to claim 7, characterized in that: The external preparation further comprises 6wt% betaine, 1wt% sodium hyaluronate and 4wt% honey.

10. The external preparation according to claim 7, characterized in that: The preparation method of the external preparation is as follows: T1: Add betaine and honey into water, heat to 60-70℃, stir and homogenize; T2: After T1 is homogenized, cool to ≤45°C, add the composition and sodium hyaluronate, homogenize, sterilize, and seal.

Citation Information

Patent Citations

  • High-penetration slimming camellia japonica massage oil and preparation method thereof

    CN107260608A

  • Atopic skin cosmetic composition and a method of manufacturing the improved

    KR1020160121293A